Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non–Small-Cell Lung Cancer: A Prospective Observational Study

2019 ◽  
Vol 20 (3) ◽  
pp. 208-214.e2 ◽  
Author(s):  
Tomoya Fukui ◽  
Yuriko Okuma ◽  
Yoshiro Nakahara ◽  
Sakiko Otani ◽  
Satoshi Igawa ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Observational Study ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Prospective Observational Study ◽  
Predictive Biomarker ◽  
Small Cell ◽  
Neutrophil To Lymphocyte Ratio ◽  
Small Cell Lung ◽  
Lymphocyte Ratio

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer

Lung Cancer ◽  
2017 ◽  
Vol 106 ◽  
pp. 1-7 ◽  
Author(s):  
Stephen J. Bagley ◽  
Shawn Kothari ◽  
Charu Aggarwal ◽  
Joshua M. Bauml ◽  
Evan W. Alley ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Neutrophil To Lymphocyte Ratio ◽  
Small Cell Lung ◽  
Lymphocyte Ratio
Sign in / Sign up

Export Citation Format

Share Document